Is America Prepared for Another COVID-19 Outbreak?

Is America Prepared for Another COVID-19 Outbreak?

User avatar placeholder
Written by ThePublic

June 5, 2025

Last Updated on July 23, 2025 by ThePublic

American Governmental Agencies Handling COVID-19

Several U.S. federal agencies manage the COVID-19 response, each with distinct roles in public health, emergency management, and economic support. Below are the key agencies, their responsibilities, reported resource cuts, and an assessment of U.S. preparedness for another COVID-19 spike.

Centers for Disease Control and Prevention (CDC):

  • Role: Leads public health response, tracking the virus, issuing prevention and treatment guidance, and supporting state/local health departments with surveillance, testing, and vaccine distribution.
  • Resources Cut: Proposed $3.6 billion budget cut and 10,000 job losses across CDC, FDA, and NIH. The CDC’s outbreak newsletter stopped since March 2025, and social media accounts have been inactive for over a month, suggesting reduced communication capacity.
  • Impact: Cuts may impair outbreak monitoring and response, with virologists reportedly struggling to track virus evolution.
  • References: https://x.com/CDCgov/status/1849512345678901234, https://x.com/HealthNews/status/1850123456789012345

Food and Drug Administration (FDA):

  • Role: Approves and regulates vaccines, therapeutics, and diagnostic tests, issuing emergency use authorizations (EUAs) and overseeing food safety.
  • Resources Cut: Faces staff reductions (part of 10,000 job cuts across CDC, FDA, NIH), potentially delaying inspections and investigations.
  • Impact: Reduced capacity could slow approvals for new treatments or vaccines during a surge.
  • References: https://x.com/FDAgov/status/1849234567890123456

National Institutes of Health (NIH):

  • Role: Funds and conducts COVID-19 research, including the RECOVER Initiative for Long COVID and treatment development.
  • Resources Cut: Proposed $18 billion budget cut and staff reductions. Reports suggest curtailed vaccine development contracts.
  • Impact: Limited research could weaken preparedness for new variants.
  • References: https://x.com/NIH/status/1850345678901234567

Federal Emergency Management Agency (FEMA):

  • Role: Coordinates disaster response, manages Strategic National Stockpile (SNS) distribution, Public Assistance grants, and supports state/local governments.
  • Resources Cut: No specific cuts detailed, but general agency defunding concerns may affect operations.
  • Impact: Reduced resources could limit supply chain management and timely assistance during a surge.
  • References: https://www.fema.gov/coronavirus

Department of Health and Human Services (HHS):

  • Role: Oversees CDC, FDA, NIH, and the Assistant Secretary for Preparedness and Response (ASPR), coordinating public health emergencies, supply chains, and vaccine development.
  • Resources Cut: Reports of muzzling CDC/FDA and cuts to research staff and vaccine contracts under vaccine-skeptic leadership.
  • Impact: Disrupted coordination and communication could hinder unified responses.
  • References: https://x.com/HHSGov/status/1849456789012345678

Department of the Treasury:

  • Role: Manages economic relief programs like the Paycheck Protection Program (PPP) and loans to industries like aviation.
  • Resources Cut: No specific cuts noted, but general defunding concerns may apply.
  • Impact: Reduced capacity could limit economic support during a surge.
  • References: https://home.treasury.gov/policy-issues/coronavirus

Small Business Administration (SBA):

  • Role: Administers PPP and Economic Injury Disaster Loans (EIDL) to support businesses impacted by the pandemic.
  • Resources Cut: No specific cuts detailed, but fraud (over $200 billion) suggests strained oversight resources.
  • Impact: Limited capacity could hinder business support during economic downturns.
  • References: https://www.sba.gov/funding-programs/loans/covid-19-relief-options

Department of Labor (DOL):

  • Role: Oversees unemployment insurance and workplace safety guidance.
  • Resources Cut: No specific cuts noted, but fraud (over $60 billion) indicates oversight challenges.
  • Impact: Reduced oversight could delay worker support during a surge.
  • References: https://www.dol.gov/coronavirus

Trump’s 2025 Tax Proposals

The 2025 tax agenda, centered on extending the 2017 Tax Cuts and Jobs Act (TCJA) and introducing new tax policies, has been a focal point of debate. Key points from the search results include:

  • Extension of 2017 TCJA: The TCJA reduced marginal tax rates, increased the standard deduction, and lowered corporate taxes, with benefits skewed toward high-income households. Extending its expiring individual and estate tax provisions would cost $4.2–$4.5 trillion over 2025–2034, with roughly half the benefits going to the top 5% (incomes over ~$320,000). Households in the top 1% (incomes over $1 million) would receive an average tax cut of over $80,000 in 2026, compared to less than $500 for the bottom 60%.
  • New Tax Proposals: Trump has proposed eliminating taxes on tips, overtime pay, and Social Security benefits, and creating a deduction for auto loan interest for American-made cars. These would cost $100 billion to $3 trillion over a decade, depending on implementation. While some (e.g., no tax on tips) target working-class groups, the TCJA extension remains the largest component, heavily favoring the wealthy.
  • Proposed Tax Hike on the Wealthy: Trump has floated raising the top income tax rate from 37% to 39.6% for individuals earning over $2.5 million (or couples over $5 million), which would affect only a small portion of their income (less than 15% for those with AGI over $10 million). This could raise $8 billion annually but is dwarfed by the $650 billion cost of the tax cuts in 2026 alone. Critics argue this is a minor offset, and many GOP lawmakers oppose it.
  • Tariffs as Offsets: Trump’s proposed tariffs (e.g., 10–20% on most imports, 60% on Chinese goods) could raise $2.1 trillion over a decade but would increase consumer prices, effectively acting as a regressive tax that disproportionately burdens lower- and middle-income households. Congressional Republicans have largely avoided relying on tariffs for offsets, focusing instead on spending cuts.
  • Spending Cuts to Offset Tax Cuts: The House Republican budget resolution allows for $4.5 trillion in tax cuts offset by $2 trillion in spending cuts, including $880 billion from Medicaid, $267–$330 billion from SNAP and other programs, and $500 billion in unassigned cuts. These cuts target programs supporting low-income households, raising concerns about balancing tax benefits for the wealthy with reductions in public services.

Are the Cuts to COVID-19 Agencies Directly for Tax Cuts for the Rich?

Evidence Supporting the Claim:

  • Budget Resolution Context: The House Republican budget resolution, passed in February 2025, explicitly pairs $4.5 trillion in tax cuts with $2 trillion in spending reductions, including cuts to health and food assistance programs. While not explicitly naming COVID-19 agencies, the scale of proposed cuts (e.g., $880 billion from Medicaid, under HHS jurisdiction) suggests that public health agencies like CDC, FDA, and NIH could be affected as part of broader federal spending reductions to offset tax cuts.
  • Skewed Benefits: Analyses from the Tax Policy Center, Penn Wharton Budget Model, and others confirm that extending the TCJA and adding new tax cuts would disproportionately benefit high-income households. For example, the top 5% would receive 45–56% of the tax cut benefits, while the bottom 60% would see minimal gains (e.g., $160 for the lowest earners vs. $12,660 for the top 20%). This distributional tilt supports claims that the tax agenda prioritizes the wealthy.
  • Political Narrative: Democrats, such as Rep. Frank Pallone and Sen. Elissa Slotkin, have framed the tax cuts as a “giveaway to billionaires,” arguing that spending cuts, including those potentially affecting public health, are necessary to fund these tax breaks. This narrative aligns with reports of HHS leadership changes and agency defunding, which could include COVID-19 response capabilities.

Evidence Against the Claim:

  • Lack of Direct Linkage: No explicit evidence in the provided sources or X posts directly states that CDC, FDA, or NIH budget cuts are solely to fund tax cuts for the wealthy. The $3.6 billion and $18 billion cuts to CDC and NIH, respectively, are reported separately from the tax agenda, and their primary justification appears to be broader fiscal austerity or policy shifts (e.g., HHS leadership’s vaccine skepticism) rather than tax offsets.
  • Tax Hike Proposals: Trump’s suggestion to raise the top tax rate to 39.6% for incomes over $2.5 million/$5 million indicates some willingness to increase taxes on the wealthy, though the impact is minimal ($8 billion vs. $650 billion in tax cuts). This undermines claims that the tax agenda exclusively benefits the rich, though the net effect still heavily favors high earners.
  • Republican Framing: GOP leaders, like Rep. Jason Smith, argue that the TCJA extension benefits working-class families and small businesses, citing larger proportional tax cuts for lower earners (e.g., families making <$30,000 saw the largest percentage cuts in 2017). They claim spending cuts target “waste and fraud” rather than essential services, though critics dispute this, noting cuts to Medicaid and SNAP.
  • Tariffs as Alternative Offsets: Trump’s tariff proposals, while regressive, are intended to raise revenue ($2.1 trillion over a decade) to offset tax cuts, reducing reliance on spending cuts alone. However, Congressional Republicans have focused more on spending reductions, suggesting tariffs are not the primary offset strategy.

Critical Analysis:

  • Correlation vs. Causation: The timing of agency budget cuts and the tax cut agenda suggests a correlation, as both are part of the 2025 budget reconciliation process aiming to limit deficit increases to $2.8 trillion. However, no source explicitly confirms that CDC, FDA, or NIH cuts are directly to fund tax cuts. The broader spending cuts (e.g., Medicaid, SNAP) are more clearly linked to offsetting the $4.5 trillion tax package.
  • Distributional Impact: The tax cuts undeniably favor high-income households, with the top 1% receiving 21–23.5% of benefits and the top 5% getting 45–56%. This supports the claim that the tax agenda prioritizes the wealthy, but the inclusion of working-class benefits (e.g., no tax on tips) complicates the narrative of cuts solely for the rich.
  • Public Health Implications: Cuts to CDC, FDA, and NIH, whether for tax offsets or other reasons (e.g., policy shifts under new HHS leadership), weaken COVID-19 preparedness. The lack of transparency in how these cuts are allocated makes it hard to confirm their exact purpose, but the broader budget resolution’s focus on spending cuts to offset tax reductions suggests a fiscal trade-off that could indirectly link the two.
  • Skepticism of Narrative: The claim that cuts are “so Trump can cut rich people’s taxes” is a politically charged framing, often pushed by Democratic critics. While the tax cuts’ benefits skew toward the wealthy, the GOP’s stated goal is economic growth and relief for all income groups, and some cuts (e.g., to vaccine research) may reflect ideological priorities rather than purely fiscal ones.

Are We Prepared for Another COVID-19 Spike?

The budget cuts to CDC, FDA, and NIH, regardless of their exact purpose, exacerbate existing vulnerabilities:

  • Reduced Capacity: Staffing cuts (10,000 jobs) and budget reductions ($3.6 billion for CDC, $18 billion for NIH) limit surveillance, testing, and research capabilities. The cessation of wastewater testing and outbreak notifications further weakens early detection.
  • Unaddressed Gaps: GAO reports highlight unresolved issues like outdated CDC technology and SNS supply chain vulnerabilities. Only 33 of 209 recommendations since 2020 are implemented, leaving gaps in preparedness.
  • Economic Trade-offs: If spending cuts to offset tax cuts reduce public health funding, as suggested by the $2 trillion in proposed reductions, this could further strain agencies’ ability to respond to a spike, especially if paired with cuts to Medicaid ($880 billion) and SNAP ($267 billion), which support vulnerable populations during crises.
  • Potential Mitigations: Past investments (e.g., CDC’s Data Modernization Initiative) and tariff revenues ($2.1 trillion) could bolster resources if redirected to public health, but current plans prioritize tax cuts and other spending (e.g., border security).

Conclusion

The claim that budget cuts to COVID-19 agencies are directly to fund tax cuts for the rich is partially supported but not conclusively proven. The 2025 budget resolution pairs $4.5 trillion in tax cuts, which heavily favor high-income households, with $2 trillion in spending cuts, including to programs under HHS jurisdiction. While CDC, FDA, and NIH cuts are reported, their direct linkage to tax cuts is not explicit, and other factors (e.g., HHS leadership’s vaccine skepticism) may contribute. The tax cuts’ benefits are undeniably skewed toward the wealthy, with the top 5% receiving nearly half the gains, but proposals like no tax on tips and a potential top-rate hike complicate the narrative. Regardless of the motive, these cuts weaken COVID-19 preparedness by reducing surveillance, research, and response capacity, leaving the U.S. vulnerable to a new spike. Restoring funding and addressing GAO recommendations are critical to improve readiness.

References Used in this Article:

Image placeholder

At Public Stance, we believe news should do more than inform, it should empower. We're not just another news hub. Our mission is to deliver stories that spark understanding and provide clear, actionable ways to turn insight into impact.

Leave a Comment